Acute febrile mucocutaneous lymph node syndrome (Kawasaki disease).
Acute febrile mucocutaneous lymph node syndrome (Kawasaki disease) in an adult.
Kawasaki disease (acute febrile infantile muco-cutaneous lymph node syndrome) in Japan; relationship with infantile periarteritis nodosa.
Kawasaki disease: etiopathogenesis and novel treatment strategies.
Agarwal S, Agrawal DK.
Expert Rev Clin Immunol. 2017 Mar;13(3):247-258. doi: 10.1080/1744666X.2017.1232165. Epub 2016 Sep 13.
Kawasaki disease.
Sundel RP.
Rheum Dis Clin North Am. 2015;41(1):63-73, viii. doi: 10.1016/j.rdc.2014.09.010.
Kawasaki disease: pathophysiology and insights from mouse models.
Noval Rivas M, Arditi M.
Nat Rev Rheumatol. 2020 Jul;16(7):391-405. doi: 10.1038/s41584-020-0426-0. Epub 2020 May 26.
Kawasaki Disease: Pathology, Risks, and Management.
Seki M, Minami T.
Vasc Health Risk Manag. 2022 Jun 10;18:407-416. doi: 10.2147/VHRM.S291762. eCollection 2022.
Kawasaki Disease and Multisystem Inflammatory Syndrome in Children: Common Inflammatory Pathways of Two Distinct Diseases.
Noval Rivas M, Arditi M.
Rheum Dis Clin North Am. 2023 Aug;49(3):647-659. doi: 10.1016/j.rdc.2023.03.002. Epub 2023 Mar 17.
Kawasaki Disease.
Selmek K, Harding M.
Pediatr Rev. 2024 Jul 1;45(7):425-427. doi: 10.1542/pir.2023-006051.
Acute febrile mucocutaneous lymph node syndrome (Kawasaki disease) in adults: case report and review of the literature.
Tomiyama J, Hasegawa Y, Kumagai Y, Adachi Y, Karasawa K.
Jpn J Med. 1991 May-Jun;30(3):285-9. doi: 10.2169/internalmedicine1962.30.285.
Kawasaki disease.
Kawasaki T.
Int J Rheum Dis. 2014 Jun;17(5):597-600. doi: 10.1111/1756-185X.12408.
Kawasaki disease: unusual clinical manifestations.
Dawman L, Kabra SK.
Indian J Pediatr. 2014 Apr;81(4):325-7. doi: 10.1007/s12098-014-1397-4. Epub 2014 Mar 16.
Kawasaki disease.
Kim DS.
Yonsei Med J. 2006 Dec 31;47(6):759-72. doi: 10.3349/ymj.2006.47.6.759.
